Grossman Jerrold B 4

Accession 0001140361-24-039821

CIK 0001368514other

View on SEC.gov Company Profile

Filed

Aug 29, 8:00 PM ET

Accepted

Aug 30, 9:02 PM ET

Size

26.9 KB

Accession

0001140361-24-039821

Insider Transaction Report

Form 4

Period: 2024-08-29

ADMA BIOLOGICS, INC.ADMA

Grossman Jerrold B

Director

Transactions

Exercise/Conversion
Common Stock
2024-08-29$10.80/sh+9,000$97,200→ 604,166 total
Exercise/Conversion
Common Stock
2024-08-29$3.66/sh+118,861$435,031→ 586,166 total
Exercise/Conversion
Common Stock
2024-08-29$10.80/sh−9,000$97,200→ 0 total
Exercise: $10.80Exp: 2025-01-30→ Common Stock (9,000 underlying)
Exercise/Conversion
Common Stock
2024-08-29$5.96/sh+9,000$53,640→ 595,166 total
Sale
Common Stock
2024-08-29$17.27/sh−136,861$2,363,932→ 467,305 total
Exercise/Conversion
Common Stock
2024-08-29$3.66/sh−118,861$435,031→ 0 total
Exercise: $3.66Exp: 2027-06-06→ Common Stock (118,861 underlying)
Exercise/Conversion
Common Stock
2024-08-29$5.96/sh−9,000$53,640→ 0 total
Exercise: $5.96Exp: 2026-01-28→ Common Stock (9,000 underlying)

Holdings

Common Stock
(indirect: See Footnote)
38,294
Common Stock
(indirect: See Footnote)
31,381
Common Stock
(indirect: See Footnote)
22,857
Common Stock
(indirect: See Footnote)
175

Footnotes (10)

[F1]The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $17.17 to $17.595. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
[F10]The Reporting Person is exercising these options due, in part, to their near-term expiration date.
[F2]Includes, as of the transaction date, (i) 12,020 restricted stock units granted on February 26, 2024, which will vest in full on February 26, 2025, subject to the Reporting Person's continued service as of the applicable vesting date; and (ii) 455,285 shares of common stock owned by the reporting person.
[F3]These shares are owned by Brookwood LLC ("Brookwood"). The reporting person is the managing member of Brookwood.
[F4]These shares are owned by the Jerrold Grossman 2019 Irrevocable Trust, of which Dr. Grossman serves as investment trustee.
[F5]These shares are owned by Genesis Foundation Inc. ("Genesis"). The reporting person is the President of Genesis.
[F6]These shares are owned by the reporting person's wife.
[F7]These options were granted on June 6, 2017 and vested in twenty-four equal monthly installments, becoming fully vested on June 6, 2019.
[F8]These options were granted on January 28, 2016 and vested in twenty-four equal monthly installments, becoming fully vested on January 28, 2018.
[F9]These options were granted on January 30, 2015 and vested in twenty-four equal monthly installments, becoming fully vested on January 30, 2017.

Documents

2 files

Issuer

ADMA BIOLOGICS, INC.

CIK 0001368514

→

Entity typeother

Related Parties

filerCIK 0001542519

Filing Metadata

Form type: 4
Filed: Aug 29, 8:00 PM ET
Accepted: Aug 30, 9:02 PM ET
Size: 26.9 KB

View on SEC.gov